If you need more lookups,
subscriptions start at $34 USD/month.
Mark Blumling Location
California, United States
Mark Blumling Work
2026 -now Advisor, Goldman Sachs Growth Equity @
2024 -now Adjunct Faculty and Lecturer @
2019 -now Member @
2010 -now Life Member @
2024 -2026 Executive Advisor @
2018 -2023 CEO, President, Founder and Board Member at Headlands Research @ Headlands Research (acquired by THL)
2014 -2017 CEO, President, Co-Founder and Board Member at Genos @
2014 -2016 President, Consumer Division and CEO at Genos @
2012 -2014 Board of Directors Member @
2008 -2011 CEO and Managing Director and Board Member @ Relevare Pharmaceuticals
2006 -2008 COO, Founder, and Board Member @ Hyperion Therapeutics (acquired by Horizon Pharma, plc)
2004 -2006 Director @ Burrill & Company
2002 -2003 Director of Strategy, Operations, and Business Development @ Orchid Biosciences
Mark Blumling Education
Stanford University
BA (Human Biology)
Stanford Law School
JD (Law)
The London School of Economics and Political Science (LSE)
MSc ((Economics))
Mark Blumling Skills
Strategy
Management
Private Equity
Start-ups
Venture Capital
Corporate Development
Mergers
Business Development
Healthcare
Entrepreneurship
Mergers & Acquisitions
Biotechnology
Pharmaceutical Industry
Lifesciences
Due Diligence
Life Sciences
Leadership
Software
Microsoft Office
Research
Marketing Strategy
Start Ups
Mergers and Acquisitions
Mark Blumling Summary
Mark Blumling, based in California, United States, is currently a Adjunct Faculty and Lecturer at Stanford Law School. Mark Blumling brings experience from previous roles at Goldman Sachs, YPO, Council on Foreign Relations and New Mountain Capital. Mark Blumling holds a BA in Human Biology @ Stanford University. With a robust skill set that includes Strategy, Management, Private Equity, Start-ups, Venture Capital and more. Mark Blumling has 5 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Blumling?
Find contact details for 700 million professionals.